Barclays lowered the firm’s price target on Colgate-Palmolive (CL) to $80 from $82 and keeps an Equal Weight rating on the shares following the earnings report. The company said it is “accelerating change in an effort to accelerate category growth and drive market share gains,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive Faces Mixed Outlook in Earnings Call
- Colgate-Palmolive price target lowered to $90 from $92 at UBS
- Colgate-Palmolive price target lowered to $87 from $88 at JPMorgan
- Colgate-Palmolive price target lowered to $94 from $100 at Evercore ISI
- Colgate-Palmolive price target lowered to $87 from $96 at Morgan Stanley